What Has Driven the Growth of the Allergy Treatment Market in Recent Years?
The allergy treatment market has seen considerable growth due to a variety of factors.
•In recent times, the market size of allergy treatments has witnessed significant growth. The market, valued at $23.09 billion in 2024, is set to escalate to a value of $24.83 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.6%.
The historical growth trend in this market is due to factors such as the rising occurrence of allergies, the growing emphasis on self-medication, an increase in healthcare expenditure, and a surge in the patient count with diverse allergy types.
What is the Market Size Forecast for the Allergy Treatment Market?
The allergy treatment market is expected to maintain its strong growth trajectory in upcoming years.
• A significant surge is anticipated in the size of the allergy treatment market over the upcoming years, projected to reach $33.21 billion in 2029, recording a compound annual growth rate (CAGR) of 7.5%.
Various factors contributing to this projected growth in the forecast period include the adoption of patient-focused methods, an increase in over-the-counter (OTC) allergy medications, the effects of globalization and urbanization, an escalation in environmental contamination, and improved access to health coverage. Noteworthy developments in the forecast period encompass enhanced diagnostic methods, strides made in immunotherapy, pioneering advancements in drug delivery technologies, partnerships formed among pharmaceutical corporations, and increased spending by manufacturers on the creation of innovative allergy treatments.
What Are The Core Factors Supporting Growth In The Allergy Treatment Market?
The escalating occurrence of allergic disorders is anticipated to drive the expansion of the allergy treatment market. Allergic conditions occur when the immune system overly responds to a usually harmless substance, referred to as an allergen. The treatments for these conditions consist of therapies using over-the-counter or prescribed medications that aid in recognizing and avoiding different allergy triggers, thereby inhibiting allergic reactions, lessening symptoms, preventing intensification of allergies, and improving a person's health. For example, data from Allergy UK, a national charity in the UK, reported in April 2024 that over 21 million people in the UK suffer from allergies. This was the most frequently recorded chronic health issue in 2022, and it is predicted that by 2026, half of Europe's population will experience at least a single allergy. Consequently, the surging occurrence of allergic conditions is fueling the growth of the allergy treatment market.
What Are The Major Segments Within The Global Allergy Treatment Market?
The allergy treatment market covered in this report is segmented –
1) By Treatment Type: Anti-Allergy Drugs, Immunotherapy
2) By Type: Eye Allergy, Skin Allergy, Food Allergy, Asthma, Rhinitis, Other Types
3) By Route of Administration: Oral, Parenteral, Nasal, Other Routes of Administration
4) By Distribution Channels: Hospital Pharmacies, Retail Pharmacies, Online Retailers, Other Distribution Channels
5) By End-Users: Hospitals, Specialty Clinics, Homecare, Other End-Users
Subsegments:
1) By Anti-Allergy Drugs: Antihistamines, Corticosteroids, Leukotriene Receptor Antagonists, Decongestants
2) By Immunotherapy: Allergy Shots, Sublingual Immunotherapy (SLIT), Oral Immunotherapy
Pre-Book The Allergy Treatment Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Trends Are Expected To Transform The Allergy Treatment Market?
The continuing evolution of technology is a crucial trend becoming increasingly favored in the allergy treatment market. To maintain their market position, leading corporations are embracing new technologies. For example, Metropolis Healthcare Limited, an Indian network of pathology labs and diagnostic centers, initiated an AI-empowered allergy component testing rooted in Component Resolved Diagnostics (CRD) in May 2023. Utilizing artificial intelligence, this component testing assists doctors in making more enlightened clinical resolutions while also providing useful insight for customizing a patient's allergy management plan. This is powered by a multiplex system based on nanotechnology, which leverages molecular components to spot specific IgE antibodies against 295 unique allergens with a straightforward blood examination and presents results for 158 food allergens, ten contact allergens, and 127 respiratory allergens.
Who Are the Key Players in the Allergy Treatment Market?
Major companies operating in the allergy treatment market include:
• Pfizer Inc.
• Johnson and Johnson
• Allergy Therapeutics PLC
• F. Hoffmann-La Roche Ltd
• AbbVie Inc.
• Novartis AG
• Merck & Co. Inc.
• Sanofi S.A.
• Thermo Fisher Scientific Inc.
• AstraZeneca
• GlaxoSmithKline PLC
• Eli Lilly and Company
• Boehringer Ingelheim International GmbH
• Regeneron Pharmaceuticals
• Bausch Health Companies Inc.
• Teva Pharmaceutical Industries Ltd.
• Almirall S.A
• Akorn Operating Company LLC
• Alembic Pharmaceuticals Limited
• ALK-Abelló A/S
• Stallergenes Greer International AG
• Adamis Pharmaceuticals
• HollisterStier Allergy
• Leti Pharma SL
What Is The Most Dominant Region In The Allergy Treatment Market?
North America was the largest region in the allergy treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allergy treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
